Since the last edition of this book, major advances have been made
in our understanding of key pathways that control tumor
progression. This has led to the development of new anticancer
agents that have the ability to block the activity of proteins
involved in neoplastic cell development and proliferation. Targeted
Therapies in Oncology, Second Edition provides a concise timely
panorama of existing targeted therapies and progress into future
anticancer treatments. These therapies notably include: Targeted
agents of immune checkpoints Signal-transduction inhibitors
Antiangiogenic agents Vascular-disrupting agents Apoptosis
modulators Stem cell inhibitors Tumor profiling for drug
development The book emphasizes the biology behind this new class
of drugs as well as the clinical achievements obtained. The
contributors to this volume stand at the cutting edge of cancer
research and treatment around the world.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!